Horizon Teprotumumab's US Advisory Cmte. Likely To Focus On Labeling, Not Approval, Questions

 
• By Derrick Gingery
  
Close-up of blue eye. High Technologies in the futuristic. : cataract
Teprotumumab is proposed to treat a rare eye condition called active throid eye disease (TED). • Source: Shutterstock

More from US FDA Performance Tracker

More from Regulatory Trackers